InvestorsHub Logo
Followers 156
Posts 6362
Boards Moderated 1
Alias Born 08/06/2004

Re: Steady_T post# 374513

Wednesday, 09/21/2022 11:03:38 PM

Wednesday, September 21, 2022 11:03:38 PM

Post# of 460261

I'm curious about why you think this is the case..."our BP partner can help expedite the approval process with the FDA.."

Anavex Rett program already has fast track, orphan drug designation, and Rare pediatric disease designation. Those are geared to obtaining FDA review and approval as fast as the FDA can move.



Good post Steady. I have often thought the same thing every time I hear that BP would move faster to expedite the approval process with the FDA, as stated many times by different people.

I say how so?

That is not the reason they want to partner for the two largest CNS diseases..

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News